病毒学
医学
呼吸系统
病毒
呼吸道感染
疾病
免疫学
内科学
标识
DOI:10.58347/tml.2023.1686a
摘要
Two recombinant vaccines, Arexvy (GSK) and Abrysvo (Pfizer), have been approved by the FDA for prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults ≥60 years old.
科研通智能强力驱动
Strongly Powered by AbleSci AI